Respiratory Department, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, 102206, China.
J Ethnopharmacol. 2023 Sep 15;313:116481. doi: 10.1016/j.jep.2023.116481. Epub 2023 Apr 16.
The combined prescription of two classical decoctions (Ma-Xing-Shi-Gan decoction with Xiao-Chai-Hu decoction), named as San-Yang-He-Zhi (SYHZ) decoction, has been widely used for the treatment of influenza virus (IFV) infections for decades.
This study aimed to evaluate the anti-influenza effect of SYHZ decoction and explore the underlying mechanism.
The ingredients of SYHZ decoction were analyzed by mass spectrometry. An animal model of IFV infection was established by challenging C57BL/6J mice with PR8 virus. Three groups of mice were infected with lethal or non-lethal doses of IFV, then followed by oral administration of phosphate-buffered saline (PBS), or SYHZ, or oseltamir; blank control mice (without IFV infection) were treated with PBS. Survival rate, Lung index, colon length, body weight loss and IFV viral load were measured 7 days post infection; histology and electron-microscopy examinations of lung tissue were performed; cytokine and chemokine levels in lung and serum were measured; and the intestinal metagenome, the cecum metabolome, and the lung transcriptome were analyzed.
SYHZ treatment significantly improved survival rate compared with PBS (40% vs 0%); improved lung index, colon length, and body weight loss; and alleviated lung histological damage and viral load. SYHZ-treated mice had significantly lower levels of IL-1β, TNF-α, IL-6, CCL2, CXCL10 in lung and serum, and increased levels of multiple bioactive components in cecum. Pro-inflammatory cytokines, Toll- and NOD-like receptors, pro-apoptosis molecules, and lung-injury-related proteins were downregulated in SYHZ mice, whereas surfactant protein and mucin were upregulated. The NOD-like receptor pathway, Toll-like receptor pathway, and NF-κB pathway were downregulated by SYHZ treatment.
SYHZ decoction alleviated IFV infection in a mouse model. Multiple bioactive ingredients of SYHZ may inhibit replication of IFV and suppress excessive immune response.
将两种经典方剂(麻杏石甘汤和小柴胡汤)组合成方剂,称为三阳合治(SYHZ)汤,已被广泛用于治疗流感病毒(IFV)感染数十年。
本研究旨在评估 SYHZ 汤的抗流感作用,并探讨其潜在机制。
采用质谱分析法分析 SYHZ 汤的成分。采用 PR8 病毒感染 C57BL/6J 小鼠建立 IFV 感染动物模型。将三组小鼠感染致死或非致死剂量的 IFV,然后口服磷酸盐缓冲盐水(PBS)、SYHZ 或奥司他韦;空白对照小鼠(未感染 IFV)用 PBS 处理。感染后 7 天测量存活率、肺指数、结肠长度、体重减轻和 IFV 病毒载量;进行肺组织的组织学和电子显微镜检查;测量肺和血清中的细胞因子和趋化因子水平;并分析肠道宏基因组、盲肠代谢组和肺转录组。
与 PBS 相比,SYHZ 治疗显著提高了存活率(40%比 0%);改善了肺指数、结肠长度和体重减轻;并缓解了肺组织学损伤和病毒载量。SYHZ 治疗组小鼠肺和血清中 IL-1β、TNF-α、IL-6、CCL2、CXCL10 水平显著降低,盲肠中多种生物活性成分水平升高。SYHZ 小鼠中促炎细胞因子、Toll 和 NOD 样受体、促凋亡分子和肺损伤相关蛋白下调,而表面活性剂蛋白和粘蛋白上调。SYHZ 治疗下调了 NOD 样受体通路、Toll 样受体通路和 NF-κB 通路。
SYHZ 汤减轻了小鼠 IFV 感染。SYHZ 的多种生物活性成分可能抑制 IFV 的复制,并抑制过度的免疫反应。